GLPG: Galapagos NV Stocks News on August 26, 2025

Galapagos Appoints Aaron Cox as Chief Financial Officer

GlobeNewswire

2 months ago

Galapagos Appoints Aaron Cox as Chief Financial Officer

$Galapagos Presented New Data at ICML 2025 From Cohort 3 of ATALANTA-1 in Relapsed/Refractory Indolent NHL Patients, Demonstrating High Complete Response and MRD Negativity Rates With CAR-T Candidate GLPG5101$

GLPG

GlobeNewswire

2 months ago

Galapagos Presented New Data at ICML 2025 From Cohort 3 of ATALANTA-1 in Relapsed/Refractory Indolent NHL Patients, Demonstrating High Complete Response and MRD Negativity Rates With CAR-T Candidate GLPG5101

GLPG

Simply Wall St.

2 months ago

Owning 37% shares,institutional owners seem interested in Galapagos NV (AMS:GLPG),

GLPG

MT Newswires

2 months ago

Galapagos Reports Positive Safety Data for GLPG5101 in Lymphoma Trial

Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Decentralized Delivery of Fresh, Early-Memory-Enriched GLPG5101 in R/R NHL

GLPG

GlobeNewswire

2 months ago

Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Decentralized Delivery of Fresh, Early-Memory-Enriched GLPG5101 in R/R NHL

Galapagos Creates New Subscription Right Plan

GLPG

GlobeNewswire

3 months ago

Galapagos Creates New Subscription Right Plan

Galapagos Announces Oral Presentations at EHA and ICML 2025 Featuring Promising New Data from ATALANTA-1 study of Investigational CAR-T Candidate GLPG5101

GLPG

GlobeNewswire

3 months ago

Galapagos Announces Oral Presentations at EHA and ICML 2025 Featuring Promising New Data from ATALANTA-1 study of Investigational CAR-T Candidate GLPG5101

Galapagos Announces Strategic Update on Proposed Separation, Executive Leadership Transition and Board Changes

GLPG

GlobeNewswire

3 months ago

Galapagos Announces Strategic Update on Proposed Separation, Executive Leadership Transition and Board Changes

Galapagos First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

GLPG

Simply Wall St.

4 months ago

Galapagos First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts

GLPG

GlobeNewswire

4 months ago

Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts

Galapagos Announces Executive Leadership Updates

GLPG

GlobeNewswire

4 months ago

Galapagos Announces Executive Leadership Updates

GLPG

MT Newswires

4 months ago

Galapagos Says CFO, COO Thad Huston to Leave Company

Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025

GLPG

GlobeNewswire

4 months ago

Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025

GLPG

Insider Monkey

4 months ago

Is Galapagos (GLPG) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?

Biotech stocks slide as Marks resignation seen being negative for sector

GLPG

TipRanks

5 months ago

Biotech stocks slide as Marks resignation seen being negative for sector

Galapagos Publishes 2024 Annual Report and Announces Annual Shareholders’ Meeting

GLPG

GlobeNewswire

5 months ago

Galapagos Publishes 2024 Annual Report and Announces Annual Shareholders’ Meeting

Galapagos to Present at Upcoming Investor Conferences

GLPG

GlobeNewswire

6 months ago

Galapagos to Present at Upcoming Investor Conferences

GLPG

Simply Wall St.

6 months ago

Galapagos (AMS:GLPG) adds €185m to market cap in the past 7 days, though investors from five years ago are still down 89%

Galapagos receives transparency notification and 13D filing from Tang Capital

GLPG

GlobeNewswire

6 months ago

Galapagos receives transparency notification and 13D filing from Tang Capital

GLPG

MT Newswires

6 months ago

Morgan Stanley Downgrades Galapagos to Underweight From Equal Weight, Adjusts Price Target to $22 From $31

GLPG

GuruFocus.com

6 months ago

Galapagos NV (GLPG) (FY 2024) Earnings Call Highlights: Strategic Shifts and Financial Resilience

Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update

GLPG

GlobeNewswire

6 months ago

Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update

GLPG

Insider Monkey

6 months ago

Galapagos NV (GLPG): A Cheap Biotech Stock to Invest In Now

GLPG

Zacks

7 months ago

Galapagos (GLPG) Loses -21.19% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

GLPG

MT Newswires

8 months ago

Galapagos Plans to Split Into Two Entities, Revise Agreement With Gilead Sciences, Reduce Workforce by 40%

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities

GLPG

GlobeNewswire

8 months ago

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities

Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GLPG

GlobeNewswire

8 months ago

Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GLPG

Simply Wall St.

8 months ago

Galapagos NV (AMS:GLPG) stock most popular amongst retail investors who own 56%, while public companies hold 25%

ASH 2024: Galapagos presents positive results for a seven-day ‘vein-to-vein’ CAR T-cell therapy

GLPG

Clinical Trials Arena

9 months ago

ASH 2024: Galapagos presents positive results for a seven-day ‘vein-to-vein’ CAR T-cell therapy

$Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma$

GLPG

GlobeNewswire

9 months ago

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024

GLPG

GlobeNewswire

10 months ago

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024

Galapagos Third Quarter 2024 Earnings: €0.74 loss per share (vs €0.39 profit in 3Q 2023)

GLPG

Simply Wall St.

10 months ago

Galapagos Third Quarter 2024 Earnings: €0.74 loss per share (vs €0.39 profit in 3Q 2023)

GLPG

GuruFocus.com

10 months ago

Galapagos NV (GLPG) Q3 2024 Earnings Call Highlights: Strong Cash Position and R&D Progress ...

Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update

GLPG

GlobeNewswire

10 months ago

Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update

EcoR1 Capital, LLC Increases Stake in Galapagos NV

GLPG

GuruFocus.com

a year ago

EcoR1 Capital, LLC Increases Stake in Galapagos NV

Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth

GLPG

GlobeNewswire

a year ago

Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth

Galapagos receives transparency notification from EcoR1 Capital

GLPG

GlobeNewswire

a year ago

Galapagos receives transparency notification from EcoR1 Capital

GLPG

GlobeNewswire

a year ago

Galapagos receives transparency notification from EcoR1 Capital

Galapagos receives transparency notification from FMR LLC

GLPG

GlobeNewswire

a year ago

Galapagos receives transparency notification from FMR LLC

GLPG

Simply Wall St.

a year ago

Even after rising 13% this past week, Galapagos (AMS:GLPG) shareholders are still down 82% over the past five years

Biotech Stock Roundup: REGN's Drug Approval, LXRX, RYTM Stocks Gain on Update & More

GLPG

Zacks

a year ago

Biotech Stock Roundup: REGN's Drug Approval, LXRX, RYTM Stocks Gain on Update & More

GLPG

Zacks

a year ago

Galapagos (GLPG) Up on FDA Nod to Begin Phase I/II Lymphoma Study

$Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma$